Pacer Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$883K Sell
17,381
-9,865
-36% -$460K ﹤0.01% 1264
2025
Q4
$803K Sell
27,246
-36,619
-57% -$995K ﹤0.01% 1569
2025
Q3
$1.65M Sell
63,865
-767
-1% -$21.4K ﹤0.01% 1177
2025
Q2
$1.78M Buy
64,632
+47,329
+274% +$1.25M ﹤0.01% 1068
2025
Q1
$491K Sell
17,303
-9,473
-35% -$336K ﹤0.01% 1455
2024
Q4
$1.11M Sell
26,776
-20,901
-44% -$999K ﹤0.01% 1301
2024
Q3
$3.19M Buy
47,677
+2,379
+5% +$218K 0.01% 786
2024
Q2
$5.38M Buy
45,298
+3,930
+10% +$497K 0.01% 567
2024
Q1
$4.41M Sell
41,368
-4,024
-9% -$406K 0.01% 602
2023
Q4
$4.51M Sell
45,392
-7,951
-15% -$669K 0.01% 590
2023
Q3
$5.51M Sell
53,343
-27,538
-34% -$3.07M 0.02% 448
2023
Q2
$9.83M Sell
80,881
-18,448
-19% -$2.46M 0.04% 384
2023
Q1
$15.3M Sell
99,329
-1,126,738
-92% -$186M 0.07% 293
2022
Q4
$220M Buy
1,226,067
+57,020
+5% +$9.32M 1.13% 8
2022
Q3
$138M Buy
1,169,047
+149,879
+15% +$22.7M 0.96% 23
2022
Q2
$146M Buy
1,019,168
+438,198
+75% +$62.6M 1.08% 10
2022
Q1
$100M Buy
580,970
+465,401
+403% +$78.4M 0.82% 12
2021
Q4
$29.4M Buy
115,569
+83,543
+261% +$24.4M 0.3% 45
2021
Q3
$12.3M Sell
32,026
-43,512
-58% -$16M 0.16% 142
2021
Q2
$17.8M Buy
75,538
+61,087
+423% +$10.9M 0.25% 56
2021
Q1
$1.89M Sell
14,451
-1,064
-7% -$154K 0.03% 532
2020
Q4
$1.62M Sell
15,515
-13,985
-47% -$1.41M 0.03% 508
2020
Q3
$2.09M Buy
29,500
+29,190
+9,416% +$2.04M 0.04% 401
2020
Q2
$20K Buy
+310
New +$17K ﹤0.01% 875

Other funds holding MRNA